ID: ALA3249322

Max Phase: Preclinical

Molecular Formula: C25H27F3NO4PS

Molecular Weight: 427.54

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  FC(F)(F)Sc1ccc2c(c1)C(=C1CCN(CC3CC3)CC1)c1ccccc1C=C2.O=P(O)(O)O

Standard InChI:  InChI=1S/C25H24F3NS.H3O4P/c26-25(27,28)30-21-10-9-19-8-7-18-3-1-2-4-22(18)24(23(19)15-21)20-11-13-29(14-12-20)16-17-5-6-17;1-5(2,3)4/h1-4,7-10,15,17H,5-6,11-14,16H2;(H3,1,2,3,4)

Standard InChI Key:  CGHKIONOVHRUHF-UHFFFAOYSA-N

Associated Targets(non-human)

Saimiri (64 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 427.54Molecular Weight (Monoisotopic): 427.1582AlogP: 7.09#Rotatable Bonds: 3
Polar Surface Area: 3.24Molecular Species: BASEHBA: 2HBD: 0
#RO5 Violations: 1HBA (Lipinski): 1HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 8.71CX LogP: 7.13CX LogD: 5.81
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.41Np Likeness Score: -0.42

References

1. Remy DC, Rittle KE, Hunt CA, Anderson PS, Arison BH, Engelhardt EL, Hirschmann R, Clineschmidt BV, Lotti VJ, Bunting PR, Ballentine RJ, Papp NL, Flataker L, Witoslawski JJ, Stone CA..  (1977)  Synthesis and stereospecific antipsychotic activity of (-)-1-cyclopropylmethyl-4-(3-trifluoromethylthio-5H-dibenzo[a,d]cyclohepten-5-ylidene)piperidine.,  20  (8): [PMID:19627] [10.1021/jm00218a005]
2. Remy DC, Rittle KE, Hunt CA, Anderson PS, Arison BH, Engelhardt EL, Hirschmann R, Clineschmidt BV, Lotti VJ, Bunting PR, Ballentine RJ, Papp NL, Flataker L, Witoslawski JJ, Stone CA..  (1977)  Synthesis and stereospecific antipsychotic activity of (-)-1-cyclopropylmethyl-4-(3-trifluoromethylthio-5H-dibenzo[a,d]cyclohepten-5-ylidene)piperidine.,  20  (8): [PMID:19627] [10.1021/jm00218a005]

Source